PET is finding numerous clinical applications, particularly in oncology, in which it is used for
staging, treatment planning, response assessment, prognostication, and recurrence …

Health technology assessment (HTA) has the objective of providing individual patients,
clinicians, and funding bodies with the highest-quality information on the net patient benefits …

The meeting of the Society of Nuclear Medicine in Toronto highlighted the importance of
PET to the medical community and to the patients we serve. The role of PET is proving to be …

Since the influential study by van Tinteren et al. published in The Lancet in 2002, there have
been an increasing number of diagnostic randomized controlled trials (RCTs) investigating …

In a very interesting editorial on the difficulties of Health Technology Assessments of new
imaging techniques [1], Højgaard raises two crucial issues that are probably in the minds of …

If such studies are performed properly, eg in accordance with the Consort criteria [4], they
provide the cornerstone of clinical research. Good studies have well-described …

I just read the article by Rogasch et al.[1] titled “Moving the goalposts while scoring―the
dilemma posed by new PET technologies.” In that article, the authors stated that in evalu …

The International Network of Agencies for Health Technology Assessment (INAHTA) is
grateful for the opportunity to respond to the criticisms made regarding Health Technology …

In a recent article on DOTmed. com entitled ''Is There Life After PET?''Wayne Webster,
founder of ProActics Consulting, wrote that ''PET is nearing the end of its life cycle and will …

Randomized controlled trials (RCTs) add important information to diagnostic accuracy
studies in the evaluation of PET and PET/CT. We evaluated how many RCTs on PET …